Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Statistical Software for Data Analysis and Clinical Trials01:12

Statistical Software for Data Analysis and Clinical Trials

858
Statistical software is pivotal in data analysis and clinical trials by providing tools to analyze data, draw conclusions, and make predictions. These software packages range from simple data management applications to complex analytical platforms, supporting various statistical tests, models, and simulation techniques. Their significance lies in their ability to handle vast amounts of data with precision and efficiency, enabling researchers to validate hypotheses, identify trends, and make...
858
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

587
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
587
Biostatistics: Overview01:20

Biostatistics: Overview

394
Biostatistics plays a crucial role in understanding and analyzing data in healthcare and biology. Biostatisticians conduct experiments, gather evidence, and draw meaningful conclusions using statistical methods and techniques. Different variables form the foundation of biostatistical analysis, allowing researchers to understand and interpret data effectively. These variables are classified into different types, each serving a specific purpose in statistical analysis.
Discrete variables are...
394
Overview of Biostatistics in Health Sciences01:19

Overview of Biostatistics in Health Sciences

2.0K
Biostatistics involves the application of statistical techniques to scientific research in health-related fields, including biology and public health. These techniques are essential for designing studies, collecting data, and analyzing it to draw meaningful conclusions. Given the complexity of biological processes, particularly in studies involving human subjects, biostatistical methods are crucial for effectively organizing and interpreting data that might otherwise obscure underlying patterns...
2.0K
Fisher's Exact Test01:08

Fisher's Exact Test

854
Fisher's exact test is a statistical significance test widely used to analyze 2x2 contingency tables, particularly in situations where sample sizes are small. Unlike the chi-squared test, which approximates P-values and assumes minimum expected frequencies of at least five in each cell, Fisher's exact test calculates the exact probability (P-value) of observing the data or more extreme results under the null hypothesis. This feature makes it especially valuable when the assumptions of...
854
Behrens–Fisher Test00:57

Behrens–Fisher Test

144
The Behrens-Fisher test is a statistical method designed to address the Behrens-Fisher problem, which arises when comparing the means of two normally distributed populations with unequal variances. Unlike the Student's t-test, which assumes equal variances, the Behrens-Fisher test allows for mean comparison without this restrictive assumption. This flexibility makes it particularly valuable in scenarios where two independent samples exhibit normality but lack variance homogeneity.
This test...
144

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rare <i>KDR</i> Variants Define a Distinct Genetic Contribution to Congenital Heart Disease.

Circulation. Genomic and precision medicine·2026
Same author

Prothrombin G20210A and Factor V Leiden Variants Are Not Associated With Thrombotic Events in Congenital Heart Disease: An Observational Trial.

Journal of the American Heart Association·2026
Same author

Nuclear Histone 3 Post-Translational Modification Profiling in Whole Cells using Spectral Flow Cytometry.

bioRxiv : the preprint server for biology·2026
Same author

Signatures of sex ratio distortion in humans.

bioRxiv : the preprint server for biology·2026
Same author

Genome sequencing is critical for forecasting outcomes following congenital cardiac surgery.

Nature communications·2025
Same author

The Utah NeoSeq Project: a collaborative multidisciplinary program to facilitate genomic diagnostics in the neonatal intensive care unit.

NPJ genomic medicine·2025

Related Experiment Video

Updated: Oct 1, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.7K

A Poisson binomial-based statistical testing framework for comorbidity discovery across electronic health record

Gordon Lemmon1,2, Sergiusz Wesolowski1,2, Alex Henrie1,2

  • 1Department of Human Genetics, University of Utah, Salt Lake City, UT, USA.

Nature Computational Science
|March 7, 2022
PubMed
Summary

We developed a new Poisson binomial-based approach (PBC) for discovering medical comorbidities in large datasets. This method accurately identifies true comorbidities while reducing false positives, improving patient outcome prediction tools.

More Related Videos

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.2K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.0K

Related Experiment Videos

Last Updated: Oct 1, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.7K
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.2K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

12.0K

Area of Science:

  • Computational biology
  • Medical informatics
  • Epidemiology

Background:

  • Accurate comorbidity discovery is crucial for patient outcome prediction.
  • Existing methods struggle with large datasets and require stratification, reducing statistical power.
  • Stratification controls for confounders like age, sex, and ancestry but limits cohort size.

Purpose of the Study:

  • To introduce a novel Poisson binomial-based approach (PBC) for big-data comorbidity discovery.
  • To develop a method that adjusts for confounding variables on a per-patient basis and models temporal relationships.
  • To create a searchable web resource of comorbidity statistics.

Main Methods:

  • Developed a Poisson binomial-based approach (PBC) for comorbidity discovery.
  • Applied PBC to two large datasets, analyzing 4,623,841 pairs of medical terms.
  • Modeled temporal relationships and adjusted for demographic confounders per patient, avoiding stratification.

Main Results:

  • The PBC approach effectively computed comorbidity statistics across millions of medical term pairs.
  • Compared to traditional methods, PBC reduced false positive associations.
  • PBC maintained statistical power for discovering true comorbidities, even with large datasets.

Conclusions:

  • The Poisson binomial-based approach (PBC) offers a scalable and powerful solution for comorbidity discovery in big data.
  • PBC enhances the accuracy of patient outcome prediction by improving comorbidity identification.
  • This method provides a valuable resource for researchers studying disease associations.